Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biopolio
- Development stage
- Phase 4
- Lead developer
- Bharat Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Oral
01
Overview
Biopolio is a **polio vaccine** developed and manufactured by Bharat Biotech for prevention of poliomyelitis caused by poliovirus. The name refers to more than one product formulation: an **inactivated trivalent poliovirus vaccine** containing Salk poliovirus types 1, 2, and 3 grown in Vero cell culture, and an **oral live-attenuated formulation** marketed as Biopolio B1/3 containing attenuated poliovirus types 1 and 3. As a vaccine, its mechanism is induction of protective humoral immunity against poliovirus antigens, thereby preventing infection-related paralysis and disease. It is used for primary immunization and booster vaccination in infants, children, and adults, and the product received WHO prequalification in March 2015.
- Brand names
- BiopolioBiopolio B1/3
- Other names
- inactivated polio vaccineoral polio vaccine
Beyond the preview
Go deeper on Biopolio.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biopolio.